Caveolin-1 modifies the immunity to Pseudomonas aeruginosa

Journal of Immunology

Volumn 184, Issue 1, 2010, Pages 296-302

  Gadjeva, Mihaela ^a   Paradis Bleau, Catherine ^a   Priebe, Gregory P ^a,b   Fichorova, Raina ^a   Pier, Gerald B ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAVEOLIN 1; LEVOFLOXACIN; MEROPENEM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL PNEUMONIA; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; IMMUNE RESPONSE; INFLAMMATION; INNATE IMMUNITY; KNOCKOUT MOUSE; LIPID RAFT; LUNG; LUNG INFECTION; MALE; MORTALITY; MOUSE; NEUTROPHIL; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN MODIFICATION; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; SPLEEN; STRAIN DIFFERENCE; WILD TYPE; ANIMAL; CYSTIC FIBROSIS; FLOW CYTOMETRY; GENETICS; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; MOUSE MUTANT;

ANIMALS; CAVEOLIN 1; CYSTIC FIBROSIS; FEMALE; FLOW CYTOMETRY; IMMUNITY, INNATE; MALE; MICE; MICE, KNOCKOUT; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 73949106560     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0900604     Document Type: Article

References (40)

1. Stover, C. K., X. Q. Pham, A. L. Erwin, S. D. Mizoguchi, P. Warrener, M. J. Hickey, F. S. Brinkman, W. O. Hufnagle, D. J. Kowalik, M. Lagrou, et al. 2000. Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature 406: 959-964.
2. Gibson, R. L., J. L. Burns, and B. W. Ramsey. 2003. Pathophysiology and management of pulmonary infections in cystic fibrosis. Am. J. Respir. Crit. Care Med. 168: 918-951.
3. Lyczak, J. B., C. L. Cannon, and G. B. Pier. 2002. Lung infections associated with cystic fibrosis. Clin. Microbiol. Rev. 15: 194-222.
4. Driscoll, J. A., S. L. Brody, and M. H. Kollef. 2007. The epidemiology, pathogenesis and treatment of Pseudomonas aeruginosa infections. Drugs 67: 351-368.
5. Grassme, H., K. A. Becker, Y. Zhang, and E. Gulbins. 2008. Ceramide in bacterial infections and cystic fibrosis. Biol. Chem. 389: 1371-1379.
6. Kowalski, M. P., and G. B. Pier. 2004. Localization of cystic fibrosis transmembrane conductance regulator to lipid rafts of epithelial cells is required for Pseudomonas aeruginosa-induced cellular activation. J. Immunol. 172: 418-425.
7. Lisanti, M. P., P. E. Scherer, J. Vidugiriene, Z. Tang, A. Hermanowski-Vosatka, Y. H. Tu, R. F. Cook, and M. Sargiacomo. 1994. Characterization of caveolinrich membrane domains isolated from an endothelial-rich source: implications for human disease. J. Cell Biol. 126: 111-126.
8. Ehrhardt, C., C. Kneuer, M. Laue, U. F. Schaefer, K. J. Kim, and C. M. Lehr. 2003. 16HBE14o- human bronchial epithelial cell layers express P-glycoprotein, lung resistance-related protein, and caveolin-1. Pharm. Res. 20: 545-551.
9. Drab, M., P. Verkade, M. Elger, M. Kasper, M. Lohn, B. Lauterbach, J. Menne, C. Lindschau, F. Mende, F. C. Luft, et al. 2001. Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science 293: 2449-2452.
10. Garrean, S., X. P. Gao, V. Brovkovych, J. Shimizu, Y. Y. Zhao, S. M. Vogel, and A. B. Malik. 2006. Caveolin-1 regulates NF-kappaB activation and lung in- flammatory response to sepsis induced by lipopolysaccharide. J. Immunol. 177: 4853-4860. (Pubitemid 44469821)
11. Chung, K. N., P. C. Elwood, and J. E. Heuser. 1996. Caveolin is necessary and sufficient for caveolae formation. Mol. Biol. Cell 7: 276a.
12. Scherer, P. E., T. Okamoto, M. Chun, I. Nishimoto, H. F. Lodish, and M. P. Lisanti. 1996. Identification, sequence, and expression of caveolin-2 defines a caveolin gene family. Proc. Natl. Acad. Sci. USA 93: 131-135.
13. Capozza, F., T. M.Williams,W. Schubert, S. McClain, B. Bouzahzah, F. Sotgia, and M. P. Lisanti. 2003. Absence of caveolin-1 sensitizes mouse skin to carcinogen-induced epidermal hyperplasia and tumor formation.Am. J. Pathol. 162: 2029-2039.
14. Kikuchi, T., N. Oka, A. Koga, H. Miyazaki, H. Ohmura, and T. Imaizumi. 2005. Behavior of caveolae and caveolin-3 during the development of myocyte hypertrophy. J. Cardiovasc. Pharmacol. 45: 204-210.
15. Abraham, S. N., M. J. Duncan, G. Li, and D. Zaas. 2005. Bacterial penetration of the mucosal barrier by targeting lipid rafts. J. Investig. Med. 53: 318-321.
16. Parolini, I., M. Sargiacomo, F. Galbiati, G. Rizzo, F. Grignani, J. A. Engelman, T. Okamoto, T. Ikezu, P. E. Scherer, R. Mora, et al. 1999. Expression of caveolin-1 is required for the transport of caveolin-2 to the plasma membrane. Retention of caveolin-2 at the level of the golgi complex. J. Biol. Chem. 274: 25718-25725.
17. Zaas, D. W., M. J. Duncan, G. Li, J. R. Wright, and S. N. Abraham. 2005. Pseudomonas invasion of type I pneumocytes is dependent on the expression and phosphorylation of caveolin-2. J. Biol. Chem. 280: 4864-4872.
18. Bajmoczi, M., M. Gadjeva, S. L. Alper, G. B. Pier, and D. E. Golan. 2009. Cystic fibrosis transmembrane conductance regulator and caveolin-1 regulate epithelial cell internalization of Pseudomonas aeruginosa. Am. J. Physiol. Cell Physiol. 297: C263-C277.
19. Pier, G. B., M. Grout, and T. S. Zaidi. 1997. Cystic fibrosis transmembrane conductance regulator is an epithelial cell receptor for clearance of Pseudomonas aeruginosa from the lung. Proc. Natl. Acad. Sci. USA 94: 12088-12093.
20. Schroeder, T. H., M. M. Lee, P. W. Yacono, C. L. Cannon, A. A. Gerçeker, D. E. Golan, and G. B. Pier. 2002. CFTR is a pattern recognition molecule that extracts Pseudomonas aeruginosa LPS from the outer membrane into epithelial cells and activates NF-κ B translocation. Proc. Natl. Acad. Sci.USA99: 6907-6912.
21. Verschoor, A., M. A. Brockman, M. Gadjeva, D. M. Knipe, and M. C. Carroll. 2003. Myeloid C3 determines induction of humoral responses to peripheral herpes simplex virus infection. J. Immunol. 171: 5363-5371.
22. Gadjeva, M., A. Verschoor, M. A. Brockman, H. Jezak, L. M. Shen, D. M. Knipe, and M. C. Carroll. 2002. Macrophage-derived complement component C4 can restore humoral immunity in C4-deficient mice. J. Immunol. 169: 5489-5495.
23. Fichorova, R. N., N. Richardson-Harman, M. Alfano, L. Belec, C. Carbonneil, S. Chen, L. Cosentino, K. Curtis, C. S. Dezzutti, B. Donoval, et al. 2008. Biological and technical variables affecting immunoassay recovery of cytokines from human serum and simulated vaginal fluid: a multicenter study. Anal. Chem. 80: 4741-4751.
24. Coleman, F. T., S. Mueschenborn, G. Meluleni, C. Ray, V. J. Carey, S. O. Vargas, C. L. Cannon, F. M. Ausubel, and G. B. Pier. 2003. Hypersusceptibility of cystic fibrosis mice to chronic Pseudomonas aeruginosa oropharyngeal colonization and lung infection. Proc. Natl. Acad. Sci. USA 100: 1949-1954.
25. Liang, K. Y., and S. L. Zeger. 1986. Longitudinal data analysis using generalized linear models. Biometrika 73: 13-22.
26. Wang, X. M., Y. Zhang, H. P. Kim, Z. Zhou, C. A. Feghali-Bostwick, F. Liu, E. Ifedigbo, X. Xu, T. D. Oury, N. Kaminski, and A. M. Choi. 2006. Caveolin-1: a critical regulator of lung fibrosis in idiopathic pulmonary fibrosis. J. Exp. Med. 203: 2895-2906.
27. Rodríguez, N. E., U. Gaur, and M. E. Wilson. 2006. Role of caveolae in Leishmania chagasi phagocytosis and intracellular survival in macrophages. Cell. Microbiol. 8: 1106-1120.
28. Kowalski, M. P., A. Dubouix-Bourandy, M. Bajmoczi, D. E. Golan, T. Zaidi, Y. S. Coutinho-Sledge, M. P. Gygi, S. P. Gygi, E. A. Wiemer, and G. B. Pier. 2007. Host resistance to lung infection mediated by major vault protein in epithelial cells. Science 317: 130-132.
29. Cohen, A.W., R. Hnasko,W. Schubert, and M. P. Lisanti. 2004. Role of caveolae and caveolins in health and disease. Physiol. Rev. 84: 1341-1379.
30. Medina, F. A., C. J. de Almeida, E. Dew, J. Li, G. Bonuccelli, T. M. Williams, A. W. Cohen, R. G. Pestell, P. G. Frank, H. B. Tanowitz, and M. P. Lisanti. 2006. Caveolin-1-deficient mice show defects in innate immunity and inflammatory immune response during Salmonella enterica serovar Typhimurium infection. Infect. Immun. 74: 6665-6674.
31. Li, J., A. Scherl, F. Medina, P. G. Frank, R. N. Kitsis, H. B. Tanowitz, F. Sotgia, and M. P. Lisanti. 2005. Impaired phagocytosis in caveolin-1 deficient macrophages. Cell Cycle 4: 1599-1607.
32. Tamilselvam, B., and S. Daefler. 2008. Francisella targets cholesterol-rich host cell membrane domains for entry into macrophages. J. Immunol. 180: 8262-8271.
33. Schroeder, T. H., N. Reiniger, G. Meluleni, M. Grout, F. T. Coleman, and G. B. Pier. 2001. Transgenic cystic fibrosis mice exhibit reduced early clearance of Pseudomonas aeruginosa from the respiratory tract. J. Immunol. 166: 7410-7418.
34. Reiniger, N., M. M. Lee, F. T. Coleman, C. Ray, D. E. Golan, and G. B. Pier. 2007. Resistance to Pseudomonas aeruginosa chronic lung infection requires cystic fibrosis transmembrane conductance regulator-modulated interleukin-1 (IL-1) release and signaling through the IL-1 receptor. Infect. Immun. 75: 1598-1608.
35. QQiu, D., V. M. Eisinger, N. E. Head, G. B. Pier, and H. D. Yu. 2008. ClpXP proteases positively regulate alginate overexpression and mucoid conversion in Pseudomonas aeruginosa. Microbiology 154: 2119-2130.
36. Zaas, D. W., Z. D. Swan, B. J. Brown, G. Li, S. H. Randell, S. Degan, M. E. Sunday, J. R. Wright, and S. N. Abraham. 2009. Counteracting signaling activities in lipid rafts associated with the invasion of lung epithelial cells by Pseudomonas aeruginosa. J. Biol. Chem. 284: 9955-9964.
37. Allewelt, M., F. T. Coleman, M. Grout, G. P. Priebe, and G. B. Pier. 2000. Acquisition of expression of the Pseudomonas aeruginosa ExoU cytotoxin leads to increased bacterial virulence in a murine model of acute pneumonia and systemic spread. Infect. Immun. 68: 3998-4004.
38. Hauser, A. R., E. Cobb, M. Bodi, D. Mariscal, J. Vallés, J. N. Engel, and J. Rello. 2002. Type III protein secretion is associated with poor clinical outcomes in patients with ventilator-associated pneumonia caused by Pseudomonas aeruginosa. Crit. Care Med. 30: 521-528.
39. Schulert, G. S., H. Feltman, S. D. Rabin, C. G. Martin, S. E. Battle, J. Rello, and A. R. Hauser. 2003. Secretion of the toxin ExoU is a marker for highly virulent Pseudomonas aeruginosa isolates obtained from patients with hospital-acquired pneumonia. J. Infect. Dis. 188: 1695-1706.
40. Roy-Burman, A., R. H. Savel, S. Racine, B. L. Swanson, N. S. Revadigar, J. Fujimoto, T. Sawa, D. W. Frank, and J. P. Wiener-Kronish. 2001. Type III protein secretion is associated with death in lower respiratory and systemic Pseudomonas aeruginosa infections. J. Infect. Dis. 183: 1767-1774.